BIMI International Medical Inc. (BIMI)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -10.25 Million | -1.27 Million | -3.51 Million | -2.06 Million | -343.97 Thousand | -908.22 Thousand |
| Net Income | -22.31 Million | -34.92 Million | -3.78 Million | -2.26 Million | -16.99 Million | -1.57 Million |
| Depreciation & Amortization | 223.56 Thousand | 244.11 Thousand | 56.04 Thousand | 261.98 Thousand | 1.03 Million | 944.01 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | 355.2 Thousand |
| Change in working capital | 2.35 Million | 6.67 Million | -2.87 Million | 164.85 Thousand | 866.07 Thousand | -666.51 Thousand |
| Other non-cash items | 9.48 Million | 26.72 Million | 3.09 Million | -222.62 Thousand | 14.75 Million | 37.49 Thousand |
| Investing Cash Flow | -536.86 Thousand | -696.51 Thousand | -724.46 Thousand | 166.71 Thousand | - | - |
| Investments in PPE | - | -814.68 Thousand | -258.96 Thousand | - | - | - |
| Acquisitions | -536.86 Thousand | -2.94 Million | -9.1 Million | 116.97 Thousand | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 338.39 Thousand | 3.06 Million | 8.63 Million | 49.74 Thousand | - | - |
| Financing Cash Flow | 8.43 Million | 6.14 Million | 3.98 Million | 1.83 Million | 211.26 Thousand | 1.05 Million |
| Debt repayment | -486.44 Thousand | -33.27 Thousand | -216.46 Thousand | -837.81 Thousand | -7.1 Million | -5.91 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 5 Million | 3.81 Million | - | - | 500 Thousand | - |
| Other Financing Activities | 3.92 Million | 2.35 Million | 4.2 Million | 2.67 Million | 6.81 Million | 6.97 Million |
| Accounts receivables | 1.35 Million | 685.42 Thousand | -4.99 Million | 48.38 Thousand | 10.85 Million | -5.13 Million |
| Accounts payables | 5.58 Million | -453.73 Thousand | 4.54 Million | -66.62 Thousand | -585.92 Thousand | 330.01 Thousand |
| Inventory | -5.47 Million | -1.43 Million | 205.58 Thousand | 106.44 Thousand | 1.05 Million | 2.74 Million |
| Other working capital | 888.52 Thousand | 7.88 Million | -2.63 Million | 76.65 Thousand | -10.45 Million | -3.74 Million |
| Cash at beginning of period | 4.6 Million | 135.3 Thousand | 1601.00 | - | 282.15 Thousand | 124.63 Thousand |
| Cash at end of period | 2.33 Million | 4.79 Million | 135.3 Thousand | 36.67 Thousand | 197.35 Thousand | 282.15 Thousand |
| Capital Expenditure | - | -814.68 Thousand | -258.96 Thousand | - | - | - |
| Effect of forex changes on cash | 85.68 Thousand | 494.24 Thousand | 386.84 Thousand | 98.64 Thousand | 47.9 Thousand | 13.28 Thousand |
| Net cash flow / Change in cash | -2.27 Million | 4.66 Million | 133.7 Thousand | 36.67 Thousand | -84.79 Thousand | 157.51 Thousand |
| Free Cash Flow | -10.25 Million | -2.09 Million | -3.77 Million | -2.06 Million | -343.97 Thousand | -908.22 Thousand |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.99 Million | 2.72 Million | -883.76 Thousand | -11.71 Million | -22.31 Million | -3.71 Million |
| Depreciation & Amortization | -17.36 Thousand | 74.81 Thousand | 53.8 Thousand | 58.31 Thousand | 223.56 Thousand | 39.46 Thousand |
| Deferred income taxes | - | - | - | - | - | -829.96 Thousand |
| Stock-based compensation | - | - | - | - | - | 829.96 Thousand |
| Change in working capital | -805.2 Thousand | -5.05 Million | 4.95 Million | 356.06 Thousand | 2.35 Million | -4.61 Million |
| Other non-cash items | 2.32 Million | 1.68 Million | -1.31 Million | 8.37 Million | 9.48 Million | 11.00 |
| Investing Cash Flow | -603.89 Thousand | - | - | -356.86 Thousand | -536.86 Thousand | -180 Thousand |
| Investments in PPE | -603.89 Thousand | - | - | - | - | - |
| Acquisitions | - | - | - | -356.86 Thousand | -536.86 Thousand | -180 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | 1.26 Million | 338.39 Thousand | - |
| Financing Cash Flow | 1.03 Million | 330.23 Thousand | -2.16 Million | 4.07 Million | 8.43 Million | 4.68 Million |
| Debt repayment | -97.18 Thousand | -38.51 Thousand | -154.7 Thousand | -179.26 Thousand | -486.44 Thousand | -266.63 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.6 Million | 1600.00 | - | 5 Million | 5 Million | 5 Million |
| Other Financing Activities | -470.05 Thousand | 367.14 Thousand | -2.01 Million | -745.32 Thousand | 3.92 Million | -43.85 Thousand |
| Accounts receivables | -130.42 Thousand | -3.45 Million | 287.76 Thousand | 1.44 Million | 1.35 Million | -1.14 Million |
| Accounts payables | 833.31 Thousand | -507.03 Thousand | -673.4 Thousand | 8.68 Million | 5.58 Million | -1.61 Million |
| Inventory | 122.33 Thousand | 529.49 Thousand | -84.38 Thousand | -6.88 Million | -5.47 Million | 1.79 Million |
| Other working capital | -1.63 Million | -1.62 Million | 5.42 Million | -2.89 Million | 888.52 Thousand | -3.64 Million |
| Cash at beginning of period | 1.93 Million | 1.73 Million | 2.33 Million | 1.04 Million | 4.6 Million | 5.03 Million |
| Cash at end of period | 994.13 Thousand | 1.93 Million | 1.73 Million | 2.33 Million | 2.33 Million | 1.04 Million |
| Capital Expenditure | -603.89 Thousand | - | - | - | - | - |
| Effect of forex changes on cash | 117.24 Thousand | 441.82 Thousand | -1.25 Million | 684.82 Thousand | 85.68 Thousand | -211.96 Thousand |
| Net cash flow / Change in cash | -937.61 Thousand | 201.68 Thousand | -606.57 Thousand | 1.28 Million | -2.27 Million | -3.98 Million |
| Free Cash Flow | -2.08 Million | -570.37 Thousand | 2.81 Million | -2.92 Million | -10.25 Million | -8.28 Million |
MAJOR
PCELL
INGRS
KTWIY
9033
MLMLF